According to the research literature titled ‘Global Multiplexed Diagnostics Market a?? Analysis By Product Type (Consumables, Instruments, Software & Services), End User, By Region, By Country (2020 Edition): Market Insights, COVID-19 Impact, Competition and Forecast (2020-2025)’, available with Market Study Report, global multiplexed diagnostics market was valued USD 9213.27 million in 2019 and is touted to grow considerably over the forecast period 2020-2025.
 

Spike in the number of people suffering from life-threatening diseases, growing prevalence of infectious diseases, and booming elderly population which are at an increased of acquiring such diseases are slated to augment global multiplexed diagnostics market growth in the upcoming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2679117/
 

Rising inclination towards innovative medical devices and technology in both developed and developing countries, intensive R&D in next-gen sequencing, and growing necessity for equipment that can simultaneously test numerous samples while keeping costs and time period to a minimal will continue to support the industry expansion in the ensuing years.
 

Further, upsurge in the production of testing solutions and maximum utilization of entire healthcare resources in 2020 due to the ravaging Covid-19 pandemic has infused growth in the market, claims the study.
 

Based on product type, global multiplexed diagnostics industry size from consumables segment is slated to garner strong returns over the forecast period. This can be attributed to escalating demand for better consumables by medical and academic researchers, and frequent procurement of reagents & assays for broadening research applications.
 

In terms of end-user, diagnostics laboratories is anticipated to gain considerable traction on the back of surging utilization of enhances consumables and instrument by healthcare personnel for performing tests and studying genomics, especially amid the pandemic.
 

Considering the geographical scope, North America, trailed by Europe and Asia Pacific, is reckoned to capture majority industry share in the forthcoming years, attributable to increasing penetration of medicinal services and surge in the number of Alzheimer’s patients due to expanding elderly population base in the region.
 

Major players in global multiplexed diagnostics industry sphere are Thermo Fisher Scientific Inc., GenMark Diagnostics Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Luminex Corp., Bio-Rad Laboratories Inc., Illumina Inc., BioMérieux SA, Agilent Technologies Inc., and Becton, Dickinson And Company.